In 2014, low- and moderate-income consumers were able to use premium subsidies to buy health coverage on Marketplaces under the Affordable Care Act. The individual health insurance market had been relatively flat for 3 years' prior.
The US individual insurance market grew 46% in 2014, the first year that consumers could buy health plans on Marketplaces created by the Affordable Care Act, according to an analysis released this week by the Kaiser Family Foundation (KFF).
The individual market grew to 15.5 million people, bolstered by the numbers of low- and moderate-income families who had premium subsidies to shop on the Marketplaces for health coverage. The KFF analysis compared enrollment data from December 2013 to December 2014, based on filings from insurers to state regulators.
About half of this enrollment explosion took place in just 4 states: California (up 843,607), Florida (up 653,997), Texas (up 505,931), and Georgia (up 330,520). On a percentage bases, states that saw the increases of more than 75% were Arkansas (168%), Rhode Island (104%), Maine (93%), New York (89%), Georgia (79%), and Florida (77%).
Authors of the analysis note that Arkansas’ increase was affected by that state’s unique waiver for Medicaid expansion. The “private option” required those consumers earning between 100% and 138% of the federal poverty line to use federal dollars to seek coverage on the private market.
Colorado and Massachusetts saw slight decreases in their individual market enrollment. Massachusetts already had implemented health reform with significant shifts in coverage patterns. In Colorado, the KFF authors write, it is believed that some who had individual coverage shifted to the Medicaid expansion.
The individual insurance market covered 10.6 million people in 2013, a figure that had held steady for at least 3 years prior to the jump in 2014, according the figures in the analysis.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More